Keyphrases
Androgen Deprivation Therapy
100%
Cardiovascular Toxicity
100%
Cardiovascular Disease
20%
Cardiovascular Risk
20%
Patient Care
20%
Prostate Cancer
20%
Prostate Radiotherapy
20%
Racial Disparities
20%
Prostate Cancer Patients
20%
Cause of Death
20%
Cancer Mortality
20%
Cancer Causes
20%
Ongoing Clinical Trials
20%
Cardiotoxicity
20%
Risk Reduction
20%
Gonadotropin-releasing Hormone Antagonist
20%
Relative Safety
20%
Infection Severity
20%
Adverse Cardiovascular Events
20%
Patients with Prostate Cancer
20%
Cardiovascular Outcomes
20%
Risk Factor Modification
20%
COVID-19 Infection
20%
COVID-19 Risk
20%
Infection Susceptibility
20%
Medicine and Dentistry
Androgen Deprivation Therapy
100%
Cardiovascular Toxicity
100%
Prostate Cancer
80%
Cardiovascular System
40%
Clinical Trial
20%
Cardiovascular Disease
20%
Patient Care
20%
Cancer Therapy
20%
Racial Disparity
20%
Cardiovascular Risk
20%
Cardiotoxicity
20%
Gonadorelin Antagonist
20%
Cancer Mortality
20%
Risk Factor Modification
20%
COVID-19
20%
Infection Sensitivity
20%
Pharmacology, Toxicology and Pharmaceutical Science
Androgen
100%
Cardiovascular Toxicity
100%
Prostate Cancer
80%
Clinical Trial
20%
Cardiovascular Disease
20%
Infection
20%
Cardiotoxicity
20%
Cardiovascular Risk
20%
Cancer Mortality
20%
Gonadorelin Antagonist
20%